Dave Bitner
About Dave Bitner
Dave Bitner is the Senior Vice President at Komodo Health with over two decades of experience in market insights and strategic planning across various pharmaceutical and healthcare companies.
Company
Dave Bitner currently works at Komodo Health as the Senior Vice President. Komodo Health is known for its innovative approach to healthcare data analytics, providing insights to improve patient care and healthcare delivery. Dave joined Komodo Health in September 2019 and brings his extensive experience in market insights and strategic planning to the organization.
Career Progression and Title
Dave Bitner is the Senior Vice President at Komodo Health. Before his current role, he served as Executive Director of Strategic Market Insights & Planning at Intercept Pharmaceuticals for one year. He has worked in significant roles such as Senior Director of Global Market Insights at Regeneron, and Regional Director for Europe-Canada Strategy & Insights at MSD. His early career started at Independence Blue Cross as a Technical Analyst.
Education and Expertise
Dave Bitner earned his Bachelor of Science in Marketing from California Polytechnic State University-San Luis Obispo. With over two decades of experience in pharmaceutical and healthcare market insights, he has contributed significantly to strategic planning across various multinational companies. His educational background laid a solid foundation for his career in specialized market insights and analytics.
International Experience
Dave Bitner has international work experience, having served as the Regional Director for Europe-Canada Strategy & Insights at MSD in Lucerne Area, Switzerland. This role saw him managing insights and strategic planning for the European and Canadian markets, showcasing his ability to operate in diverse international environments.
Background in Market Insights and Analytics
Dave Bitner has a rich background in market insights and analytics, having held roles such as Senior Director of Global Market Insights at Regeneron and Director of Cardiovascular Global Insights & Analytics at Merck. His expertise spans cardiovascular, ophthalmic markets, and specialty products, highlighting his ability to deliver critical insights and strategic recommendations across various therapeutic areas.